The pathological study indicated that increased density of CD204+ TAMs was closely associated with cancer cell proliferation and worse clinical course in breast cancer, and the density of CD204+ TAMs was a significant prognostic factor rather than the density of CD68+ or CD163+ TAMs [85]. This evidence concerns the gene CD163 and breast carcinoma.